Share Name Share Symbol Market Type Share ISIN Share Description
Cenkos Securities Plc LSE:CNKS London Ordinary Share GB00B1FLHR07 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 54.00 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
54.00 56.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 25.92 0.15 -0.20 31
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 54.00 GBX

Cenkos Securities (CNKS) Latest News

More Cenkos Securities News
Cenkos Securities Investors    Cenkos Securities Takeover Rumours

Cenkos Securities (CNKS) Discussions and Chat

Cenkos Securities Forums and Chat

Date Time Title Posts
30/11/202011:51Cenkos - Racing to the top?3,576
11/7/201613:04*** Cenkos Securities ***3
31/3/201512:18CNKS Cenkos228
23/11/201408:31$CNKS.L – investing is never easy-
04/7/201110:59Cenkos Securities7

Add a New Thread

Cenkos Securities (CNKS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-12-02 16:35:2854.003,0001,620.00UT
2020-12-02 13:35:2154.425,0002,721.00O
2020-12-02 13:35:1754.425,0002,721.00O
2020-12-02 13:19:4454.5025,00013,625.00O
2020-12-02 12:34:2054.4220,00010,884.00O
View all Cenkos Securities trades in real-time

Cenkos Securities (CNKS) Top Chat Posts

Cenkos Securities Daily Update: Cenkos Securities Plc is listed in the General Financial sector of the London Stock Exchange with ticker CNKS. The last closing price for Cenkos Securities was 54p.
Cenkos Securities Plc has a 4 week average price of 45.50p and a 12 week average price of 45p.
The 1 year high share price is 66.50p while the 1 year low share price is currently 29.50p.
There are currently 56,694,783 shares in issue and the average daily traded volume is 65,637 shares. The market capitalisation of Cenkos Securities Plc is £30,615,182.82.
topvest: There is also another US$15m of total fees in sight on the US$750M placing programme. Cenkos are lined-up to deliver this, so I would expect more fees to come hopefully. Round Hill certainly appears to have an initial target of over US$ 1BN to invest. Placing Programme expenses The costs and expenses of the Company relating to the Placing Programme are those that arise from, or are incidental to, the issue of Shares pursuant to Subsequent Placings. These include the fees payable in relation to each subsequent Admission, including listing and Admission fees, as well as fees and commissions due under the Placing and Offer Agreement and any other applicable expenses in relation to the Placing Programme. It is currently anticipated that the costs and expenses of any Subsequent Placing will not exceed 2 per cent. of the gross proceeds of the relevant Subsequent Placing and will be borne by the holders of the Ordinary Shares or C Shares (as the case may be) as outlined below. The costs and expenses of issuing Ordinary Shares pursuant to any Subsequent Placing will be covered by issuing such Ordinary Shares at the prevailing published Economic Net Asset Value per Ordinary Share at the time of issue together with a premium to at least cover the costs and expenses of the relevant Subsequent Placing (including, without limitation, any placing commissions). The costs of any issue of C Shares will be allocated solely to the C Share pool of assets.
brucie5: Bought in this morning. CNKS seems to have weathered the storm, and I can see a gap on the two month chart to 70p. On the 3 year view this was of course £1, so who knows.
topvest: Yes, great news. Remember there will almost certainly be the continued placing programme as well now, as there will be demand and publicity. Maybe they were a week or so early on the timing. US$ 282m so far. That's material to H2. Share price - no change so far. Is everyone asleep. Well that's a surprise. You can never predict what share prices do!
topvest: Tomorrow morning then for the Round Hill announcement. Share price not really giving any indications one way or the other which is how its supposed to be!
topvest: Golden cross chart formation very close. Share price 53.5p 200 MDA 48.75p 50 MDA 48.56p Relative strength picking up at 61. Will it explode or flop!
smicker: One of the ex directors seems to be unloading his holding. Unlikely much will happen until he completes from a share price perspective. Probably explains some of the lack of enthusiasm.
quepassa: Yes a very big fee for Cenkos on Calnex. Not surprised that this moved the dial significantly on the share price today once the quantum of the fee became apparent. Herewith a link to a visualisation and summary of some of the recent transactions executed by Cenkos:- hXXps:// ALL IMO. DYOR. QP
speedsgh: Re today's AGM statement... "continues to win new clients and to raise funds for its clients." By my calcs a net gain of 3 new clients (2 if one includes unconfirmed loss of DGOC mandate) NEW CLIENTS (7) Davenport Resources (ASX:DAV) - CNKS appointed UK broker Getech Group (GTC) - CNKS appointed Nomad/sole broker (replace WH Ireland) Pelatro (PTRO) - CNKS appointed Nomad/sole broker (replace finnCap) Caribbean Investment Holdings Ltd (CIHL) - CNKS appointed Nomad/sole broker at IPO (no funds being raised on admission) InfraStrata (INFA) - CNKS appointed Nomad/sole broker (replace Allenby Capital as Nomad/joint broker; replace Arden Partners as joint broker) One Media IP Group (OMIP) - CNKS appointed sole broker (replace Panmure Gordon) NextEnergy Solar Fund Ltd (NESF) - CNKS appointed sole financial adviser/joint broker (alongside Shore Capital) LOST CLIENTS (4) Sativa Group (NEX: SATI) - CNKS replaced as corporate adviser by Peterhouse Capital Angling Direct (ANG) - CNKS replaced as Nomad/sole broker by N+1 Singer GCP Asset Backed Income Fund (GABI) - CNKS replaced as sole broker/financial adviser by Investec Bank Beeks Financial Cloud Group (BKS) - CNKS replaced as Nomad/sole broker by Canaccord Genuity * as per post 3447, looks like Cenkos may also have lost DGOC as a client upon their move up to the Main Market Are the new clients acquired of the same quality as the lost clients? "the Company's revenues in the first five months of this year are ahead of the same period for last year." The past 3 months has seen an abnormally high level of fundraising activity on the markets with many companies undertaking placings to bolster/shore up their balance sheets. Despite Cenkos revenues being ahead of the same 5-month period in 2019 (H1 figures below give context over a longer timeframe), the flurry of fundraisings seems to have largely passed Cenkos by. In such an environment I would be expecting Cenkos to not just outperform H1 2019 but H1 in several other years also. Time will tell. H1 REVENUE 2011: £25.1m 2012: £20.2m 2013: £20.0m 2014: £65.2m (AA IPO) 2015: £53.1m (BCA Marketplace IPO) 2016: £15.3m 2017: £29.2m 2018: £18.1m 2019: £10.6m
speedsgh: Hi QP. I am not qualified to make a qualitative comparison between WHI & CNKS. However the CNKS TU of 19/12 was backward-looking (and I am guessing largely as a result of the fees earned on the ESUR takeover which completed in Dec) whereas the WHI statement today is forward-looking so of potential relevance to all sector peers. AFAICT CNKS have been involved in just 2 fundraisings in Jan/Feb 2019: a £1.15m subscription for Personal Group (PGH) & a £21m placing/open offer for Kromek Group (KMK). Whilst 2 months does not make a year, it is interesting to compare Jan/Feb performance to recent years (based on fundraisings announced): Jan/Feb 2016: £270m Jan/Feb 2017: £163m Jan/Feb 2018: £54m Jan/Feb 2019: £22.15m Numis AGM Update on 5/2/19: "Since the start of the financial year [on 1/10/2018], UK equity indices have suffered material declines and the domestic political situation has significantly impacted investor sentiment in the UK. As a result the market backdrop has been particularly challenging for our corporate and institutional clients, which has ultimately impacted our trading performance in the first four months of the year... ... We have a good pipeline of opportunities, and would expect to see a meaningful increase in revenue, as and when there is greater clarity regarding the UK macro-economic and political landscape." All this would suggest that times are tough for the sector. AFAICS possible short-term drivers of CNKs share price: > Corporate action > Removal of Brexit uncertainty allowing UK plc to start investing again which would be beneficial for the sector AIMHO
speedsgh: Just some thinking out loud... Intriguing situation with Cenkos. Activist investor, Crystal Amber (CRS), notified Cenkos that it held 7.14% of the company in Feb 2018. No further update in their holding has been made since so one assumes they hold around the same level today (the Monthly NAV release for Dec 2018 on the CRS website actually shows them as owning 6.9% of Cenkos share capital). In their final results released on 7/9/18, Crystal Amber made the following comment: "The Fund has been a shareholder in Cenkos since late 2010 and increased its holding significantly during January 2018 at a share price which we believe ascribes little probability to the company being able to secure any further exceptionally large deals. Given the pressing need to deal with forthcoming retirement/succession issues relating to a number of Cenkos’s founders and the evident strategic interest in this sector (2017 takeover of Panmure Gordon and 2016 Kuwaiti investment in WH Ireland), we have now proposed to the board that it undertakes a strategic review of the company." Following this: CNKS rns dd 9/10/18 - CEO Anthony Hotson to stand down from the Board on 31/10/18 but remain an employee until 31/12/18. CNKS rns dd 31/10/18 - Anthony Hotson to remain an executive director & CEO until his successor has received FCA regulatory approval. CNKS rns dd 5/11/18 - Former CEO, Jim Durkin, to be appointed executive director & CEO upon receipt of regulatory approval; Antony Hotson to remain CEO in the interim. CNKS rns dd 12/12/18 - CFO Philip Anderson (appointed by Anthony Hotson in Jan 2018) to step down from the Board & leave Cenkos on 31/3/19. Anthony Hotson is still interim CEO today & regulatory approval of Jim Durkin remains outstanding. By way of comparison Anthony Hotson was announced as CEO on 5/7/17 subject to regulatory approval which was subsequently received less than a month later on 2/8/17. Regulatory approval of Jim Durkin's reappointment as CEO would therefore seem to be taking some time i.e. more than 3 months so far. I believe another poster has previously suggested that they have been unable to find evidence of Jim Durkin's application having been lodged with the FCA. If this is correct, what (if anything), does this indicate? Cenkos have lost their position as broker to no less than 10 clients since Aug 2018. AA (AA.), Michelmersh Brick Holdings (MBH), IG Design Group (IGR), Restore (RST), Comptoir Group (COM), Mercia Technologies (MERC), Science in Sport (SIS), Verseon Corporation (VSN), CML Microsystems (CML), Frontier IP Group (FIPP). Some of these would appear to be from the 'better quality' end of the Cenkos client portfolio. Over the same period Cenkos have independently acquired 3 new clients - Falcon Oil & Gas Ltd (FOG), Venture Life Group (VLG), Landore Resources Ltd (LND) - as well as the 12 Smith & Williamson clients upon completion of the acquisition of its Nomad & Corporate Broker business in Dec 2018. Clients acquired would appear to be lower quality than those lost. Crystal Amber "increased its holding significantly during January 2018 at a share price which we believe ascribes little probability to the company being able to secure any further exceptionally large deals." The share price in Jan 2018 was north of 100p so one would assume that they are not overly happy with the current share price. Having said that their stats as an activist investor would suggest that they have a plan in place & will be actively engaging with the Cenkos board in order to create longer term value so they may be less concerned over the share price in the short term. Whether the objectives/strategy of the Cenkos board aligns with those of Crystal Amber remains to be seen. Notwithstanding their involvement as adviser to esure Group (ESUR) in their £1.2bn takeover by Bain Capital (first announced in Aug 2018 & completed in Dec 2018), Cenkos fundraising activity would appear to have been pretty thin on the ground since Sept 2018. How much of this is company specific remains to be seen, although it is without doubt that the handling of the Brexit process by UK parliament, the uncertainty that this has created and consequent postponement of investment decisions by UK PLC has been unhelpful to the UK fundraising market in general. It will be interesting to note any commentary on Cenkos by Crystal Amber in their Interim Results which are scheduled to be released on or after 7/3/19.
Cenkos Securities share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Cenkos Sec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201203 07:36:39